Super-refractory status epilepticus: epidemiology, early predictors, and outcomes

Intensive Care Med. 2017 Oct;43(10):1532-1534. doi: 10.1007/s00134-017-4837-6. Epub 2017 May 11.

Authors

Anne-Laure Chateauneuf¹, Jean-Denis Moyer¹, Gwenaelle Jacq¹, Sébastien Cavelot¹, Jean-Pierre Bedos¹, Stephane Legriel^{2

3

4}

Affiliations

¹ Intensive Care Unit, Versailles Hospital, 177 rue de Versailles, 78150, Le Chesnay Cedex, France.
² Intensive Care Unit, Versailles Hospital, 177 rue de Versailles, 78150, Le Chesnay Cedex, France. slegriel@ch-versailles.fr.
³ Sorbonne Paris Cité-Medical School, Paris Descartes University, Paris, France. slegriel@ch-versailles.fr.
⁴ INSERM U970, Paris Cardiovascular Research Center, Paris, France. slegriel@ch-versailles.fr.

PMID: 28497271
DOI: 10.1007/s00134-017-4837-6

No abstract available

Publication types

Letter

MeSH terms

Aged
Anticonvulsants / therapeutic use
Central Nervous System Infections / complications
Central Nervous System Infections / therapy
Critical Illness / therapy
Disease Progression*
Female
Humans
Intensive Care Units
Length of Stay
Male
Middle Aged
Recurrence
Retrospective Studies
Secondary Prevention
Status Epilepticus / mortality
Status Epilepticus / prevention & control
Status Epilepticus / therapy*
Treatment Outcome

Substances

Anticonvulsants